Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
Johnson & Johnson reached a proposed agreement to resolve roughly 76,000 remaining ovarian talc claims for a total commitment of $5.5 billion. The resolution, conditioned on 95% claimant participation, follows a favorable MDL court ruling regarding specific causation and allows the company to eliminate significant litigation expenses.
Key figures
- Deal Value Usd
- $5.5 billion
- Claims count
- 76000
- First payment
- no more than $3 billion in 2027
- Participation threshold
- 95%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.